Mukka Proteins Ltd (MUKKA) — shareholding pattern, promoter holding, financials and share price
About Mukka Proteins Ltd (MUKKA)
Mukka Proteins Ltd operates in the Animal Feed industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as MUKKA and on the BSE under scrip code 544135. Its ISIN is INE0CG401037.
Incorporated in 2003, Mukka Proteins Ltd is a manufacturer and exporter of Fish Meal and Fish oil [1]
Mukka Proteins Limited is an integrated marine- and alternative-protein company that manufactures and exports fishmeal, fish oil, fish soluble paste, and operates a growing Black Soldier Fly (BSF) insect-protein and waste-to-value platform, alongside frozen seafood and leachate treatment businesses, with manufacturing assets in India and Oman and a large export footprint across 25+ countries.
Q3 FY26 showed a large top-line spike to ₹653.5 crore versus ₹244.6 crore in Q2 FY26 and ₹303.2 crore in Q3 FY25, reflecting consolidation of recent acquisitions, a sizeable leachate order recognition and strong export demand; however EBITDA margins compressed to 8.1% in Q3 indicating mix and project execution impacts on profitability.
Listed peers in Animal Feed: Avanti Feeds Ltd, Godrej Agrovet Ltd, KSE Ltd, Shivam Chemicals Ltd, Narmada Agrobase Ltd, Mayank Cattle Food Ltd.
Valuation & Returns
10 Jul 2026At ₹23.19 a share on 10 Jul 2026, Mukka Proteins Ltd (MUKKA) was valued at a price-to-earnings ratio of 12.19x against an industry P/E of 45.12x and a price-to-book of 1.58x on a book value of ₹14.69 per share as of Mar 2025. Solomo computes return on equity of 12.95% and return on capital employed of 14.41% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 12.19x
- Industry P/E
- 45.12x
- P/B
- 1.58x
- EPS (TTM)
- ₹1.9
- Book value / share
- ₹14.69
- ROE
- 12.95%
- ROCE
- 14.41%
- ROA
- 5.3%
- Debt / equity
- 1.03x
- Dividend yield
- 0%
- EBITDA margin
- 10.35%
- 52-week range
- ₹18.32 – ₹31.2
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Mukka Proteins Ltd (MUKKA) reported revenue of ₹1,449 crore, net profit of ₹57 crore and earnings per share of ₹1.74. That compares with revenue of ₹1,006 crore and net profit of ₹48 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹381 crore and net profit ₹21 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 770 | 1,177 | 1,380 | 1,006 | 1,449 |
| Net profit (₹ cr) | 26 | 48 | 74 | 48 | 57 |
| EPS (₹) | 1.1 | 2 | 2.34 | 1.55 | 1.74 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 10.20% | 8.57% | -27.06% |
| Profit growth | 26.56% | 28.12% | -35.27% |
| Stock price CAGR | - | - | -23% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 73.33% of Mukka Proteins Ltd (MUKKA) (unchanged from the previous quarter), foreign institutional investors (FII) hold 1.73%. Market capitalisation was ₹696 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2024.
Largest disclosed public shareholders in Jun 2026: CRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUND 1.19%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 73.33% | - | 1.73% | - | 26.67% |
| Mar 2026 | 73.33% | - | 1.7% | 0% | 26.67% |
| Dec 2025 | 73.33% | - | 1.7% | 0.17% | 26.67% |
| Sep 2025 | 73.33% | - | 1.7% | 1.66% | 26.67% |
| Jun 2025 | 73.33% | - | 2.08% | 1.87% | 26.67% |
| Mar 2025 | 73.33% | - | 2.63% | 1.98% | 26.67% |
| Dec 2024 | 73.33% | - | 2.63% | 1.98% | 26.67% |
| Sep 2024 | 73.33% | - | 2.82% | 2% | 26.67% |